Fig. 2.
Kaplan–Meier estimates of overall survival (a) and progression-free survival (b) comparing chemotherapy alone and chemotherapy combined with immune checkpoint inhibitors (ICIs). mOS median overall survival, HR hazard ratio, ICI + chemo the group of patients receiving immune checkpoint inhibitors and chemotherapy, Chemo the group of patients receiving chemotherapy